ABCL
Price
$3.20
Change
+$0.05 (+1.59%)
Updated
Jun 13 closing price
Capitalization
955.15M
58 days until earnings call
EVGN
Price
$1.38
Change
-$0.14 (-9.21%)
Updated
Jun 13 closing price
Capitalization
10.46M
52 days until earnings call
Interact to see
Advertisement

ABCL vs EVGN

Header iconABCL vs EVGN Comparison
Open Charts ABCL vs EVGNBanner chart's image
AbCellera Biologics
Price$3.20
Change+$0.05 (+1.59%)
Volume$7.09M
Capitalization955.15M
Evogene
Price$1.38
Change-$0.14 (-9.21%)
Volume$674.24K
Capitalization10.46M
ABCL vs EVGN Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. EVGN commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and EVGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (ABCL: $3.20 vs. EVGN: $1.38)
Brand notoriety: ABCL and EVGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 145% vs. EVGN: 24%
Market capitalization -- ABCL: $955.15M vs. EVGN: $10.46M
ABCL [@Biotechnology] is valued at $955.15M. EVGN’s [@Biotechnology] market capitalization is $10.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileEVGN’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • EVGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and EVGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while EVGN’s TA Score has 7 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 4 bearish.
  • EVGN’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, EVGN is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +31.15% price change this week, while EVGN (@Biotechnology) price change was +25.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

EVGN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($955M) has a higher market cap than EVGN($10.5M). ABCL YTD gains are higher at: 9.215 vs. EVGN (-26.203). EVGN has higher annual earnings (EBITDA): -14.42M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. EVGN (9.85M). EVGN has less debt than ABCL: EVGN (13M) vs ABCL (67.8M). ABCL has higher revenues than EVGN: ABCL (23.1M) vs EVGN (6.77M).
ABCLEVGNABCL / EVGN
Capitalization955M10.5M9,095%
EBITDA-211.2M-14.42M1,465%
Gain YTD9.215-26.203-35%
P/E RatioN/A0.30-
Revenue23.1M6.77M341%
Total Cash605M9.85M6,143%
Total Debt67.8M13M522%
FUNDAMENTALS RATINGS
EVGN: Fundamental Ratings
EVGN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLEVGN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGGHX39.00-0.25
-0.64%
American Funds Global Balanced R2E
VYRIX12.16-0.12
-0.98%
VY® T. Rowe Price Divers Mid Cap Gr R6
MMNBX9.77-0.10
-1.01%
MassMutual Diversified Value Y
RLUSX16.67-0.22
-1.30%
Lazard US Equity Focus R6
AASMX21.57-0.45
-2.04%
Thrivent Small Cap Stock A

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.59%
CRSP - ABCL
61%
Loosely correlated
+0.19%
ABSI - ABCL
58%
Loosely correlated
-2.11%
RXRX - ABCL
57%
Loosely correlated
-4.84%
NTLA - ABCL
56%
Loosely correlated
-0.48%
BEAM - ABCL
56%
Loosely correlated
-2.18%
More

EVGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVGN has been loosely correlated with CARM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EVGN jumps, then CARM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
-9.21%
CARM - EVGN
58%
Loosely correlated
-17.62%
INSM - EVGN
33%
Poorly correlated
+1.91%
NKTR - EVGN
32%
Poorly correlated
-1.94%
PMVP - EVGN
31%
Poorly correlated
-0.92%
ABCL - EVGN
29%
Poorly correlated
+1.59%
More